DigestRedComo funciona
Red
/
Empresas
Co
No verificado

Cognito Therapeutics

Sobre qué escribimos

CienciaIndustriaIr de comprasMedicina - VariosSalud

18 Comunicados de prensa

Ver todos los comunicados de prensa
03/12/2025
Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
18/11/2025
Software
Ciencia
Hardware
Ir de compras
Técnica
Material médico sanitario
Medicina - Varios
Biotecnología
Tercera edad
Salud
Eventos
Industria
Cognito Therapeutics to Present New Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
13/11/2025
WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate Neurotherapies with AI-powered Research
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
28/07/2025
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
17/07/2025
Eventos
Industria
Tercera edad
Biotecnología
Salud
Material médico sanitario
Ir de compras
Medicina - Varios
Cognito Therapeutics to Present Five Abstracts at AAIC 2025 Highlighting Spectris™ Treatment in Alzheimer’s Disease
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
01/07/2025
Salud
Material médico sanitario
Sanidad
Medicina - Varios
Ciencia
Industria
Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
11/06/2025
Cognito Therapeutics Announces Non-invasive Neuromodulation Therapy Delays Alzheimer’s Disease Progression
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
02/04/2025
Cognito Therapeutics Announces Spectris™ Data Demonstrating Brain Structural Maintenance and Mechanism of Action in Alzheimer’s Disease at AD/PD™ 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
25/03/2025
Eventos
Industria
Técnica
Material médico sanitario
Medicina - Varios
Software
Biotecnología
Hardware
Salud
Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0
12/02/2025
Cognito Therapeutics Strengthens Executive Team to Drive Next Phase of Growth and Commercialization
Fuente
Cognito Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0